Viewing nowCombinationTelodown 40/10 mg
Telmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Il Yang Pharmaceutical Co., Ltd.

MFDS item code 201906991 · Approved 2019.09.30 · Insurance code 641705740
Treatment of hypertension; improvement of dyslipidemia; inhibition of atherosclerosis progression and prevention of cardiovascular disease
This medication is used for patients who need to take both active ingredients, telmisartan and rosuvastatin. Telmisartan is primarily used to treat essential hypertension and helps reduce the risk of myocardial infarction, stroke, and cardiovascular-related mortality in patients at high risk for cardiovascular disease. It is especially useful in high-risk patients who cannot use ACE inhibitors. Rosuvastatin helps treat hypercholesterolemia and mixed dyslipidemia and is used as an adjunct when dietary management is insufficient. Additionally, it lowers cholesterol levels in patients with hypercholesterolemia, delays the progression of atherosclerosis, and reduces the risk of cardiovascular diseases, strokes, and myocardial infarctions. Therefore, this medication effectively improves the risk of cardiovascular disease through the management of blood pressure and blood lipids.
This medication is administered only to adults. The dose should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan and rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to up to 80 mg once daily. When this medication is coadministered with a thiazide diuretic such as hydrochlorothiazide, an additional blood pressure-lowering effect is observed. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medication is 80 mg orally once daily. The effect of doses below 80 mg on reducing the risk of cardiovascular morbidity and mortality is unknown. When starting treatment with this medication to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. 3. Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication, and should continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medication to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 5. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medication is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medication (a combination product containing the same amounts of each individual active ingredient) for convenience.
This medication may cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication, and fertile women should use appropriate contraception. Patients with severely impaired liver function or with bile flow problems should not take this medication. Patients with muscle disorders or a history of muscle-related side effects need to take special precautions when taking this medication. Patients with severely impaired kidney function are also prohibited from taking this medication. There may be increased risks when taken with specific other medications, so it is advisable to consult a doctor. Elderly patients, those with hyperkalemia, and patients with moderately impaired liver function should use this medication with caution and should undergo regular liver function tests and blood tests. If symptoms of muscle pain or weakness occur, immediate notification to healthcare professionals is required, and blood tests may need to be conducted to check for muscle damage. This medication can affect the liver and kidneys, so regular testing is necessary, and if abnormal symptoms occur, it should be stopped immediately and advice from a professional should be sought. Furthermore, excessive alcohol consumption should be avoided, and interactions with other medications should be monitored. Caution is advised while driving or operating machinery as dizziness or drowsiness may occur. It should be stored in a safe place out of reach of children, and it is recommended to keep it in its original container.
Headache, positional dizziness, sleep paralysis, elevated blood pressure, decreased blood pressure, hypotension, ALT elevation, dysuria, rhinitis, discomfort in the oropharynx, pulmonary disease, unspecified gastrointestinal disorders, benign gastrointestinal neoplasms, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory tract infections, urinary tract infections, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reactions, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal bloating, vomiting, abdominal discomfort, dry mouth, liver dysfunction, liver impairment, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendinopathy, acute renal failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, increased liver enzymes, elevated serum CK, decreased hemoglobin, hypoglycemia, angioedema, hypersensitivity reaction including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptom drug reaction syndrome, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, severe muscle weakness, ocular muscle weakness, hypotension, tachycardia, bradycardia, dizziness, acute renal failure, hypoglycemia, asthenia, hunger, cold sweat, hand tremors, impaired concentration, seizure, consciousness disturbance, angioedema, facial edema, rash, alopecia, conjunctivitis, tinnitus, petechiae, shock, loss of consciousness, liver dysfunction, jaundice, anaphylaxis-like symptoms, interstitial pneumonia, rhabdomyolysis, palpitations, fatigue, nausea, lack of effect, facial spasms, sensory abnormalities, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, edema, decreased libido, facial edema, alopecia, petechiae, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, arthralgia, fatigue, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal bloating, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture and is best kept at a temperature between 1 degree and 30 degrees Celsius.
Bright blue oval film-coated tablet
30 tablets/box [10 tablets/PTP*3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Il Yang Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.